Komori
COSMOS Pharmaceutical (3349) · FactPlanned Director Retirement Updated

Change in the Representative Chairman and President

First written in FY2017. . Latest entry: FY2026.

5entries
10years
1from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseOtherFY2017 – FY20262017: 12018: 120182019: 020192020: 020202021: 120212022: 020222023: 020232024: 020242025: 020252026: 22026
Same theme, other companies

The whole theme swung hardest in 2025: 4 of 27 companies on the "Worse" side.

16 other companies' latest entry also says "Other".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 73 companies compared. The sentences above are computed from all 73.
Full recordFilings, disclosures and news, newest first
  1. FY2026Planned Director Retirement UpdatedAnnual report

    「Shibata Futoshi (柴田太) is scheduled to retire as a director at the annual general meeting of shareholders to be held on 28 August 2026.」

    The disclosure states that Director and General Manager of the Legal Department Shibata Futoshi (柴田太) is scheduled to retire at the conclusion of the annual general meeting of shareholders scheduled for 28 August 2026.
  2. 2026-08-04OtherGeneral Meetings of Shareholders

    「Representative Director and President Yokoyama Hideaki (横山 英昭)」

    The candidate biographies confirm that Yokoyama Hideaki (横山 英昭) will continue as Representative Director and President.
  3. FY2021Change in position of Representative Director and ChairmanAnnual report

    「August 2021 Our company’s Chairman of the Board (currently in office)」

    Uno Masaaki (宇野正晃) changed from Representative Director and Chairman to Chairman of the Board. Yokoyama Hideaki (横山英昭) has continued as Representative Director and President.
  4. FY2018Change of Representative Director and PresidentAnnual report

    「June 2018 Representative Director and President of the company (incumbent)」

    The representative president changed from Shibata Futoshi (柴田 太) to Yokoyama Hideaki (横山 英昭) in June 2018; Shibata Futoshi (柴田 太) became director and general manager of the Corporate Planning Department.
  5. FY2017First statedAnnual report

    「August 2017 Our company’s Representative Director and Chairman (currently in office) August 2017 Our company’s Representative Director and President (currently in office)」

    The disclosure states that Uno Masaaki (宇野正晃) became Representative Director and Chairman and Shibata Futoshi (柴田太) became Representative Director and President in August 2017.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for COSMOS Pharmaceutical yet. It last moved in the General Meetings of Shareholders of 2026-08-04: "Other".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Change in the Representative Chairman and President | COSMOS Pharmaceutical Corporation (3349) | Komori